Expectant mothers with excessive gestational weight gain have a higher risk of delivering a large-for-gestational age (LGA) infant than those whose weight gain falls within standard guidelines, according to a recent study in Obstetrics & Gynecology.
Expectant mothers with excessive gestational weight gain have a higher risk of delivering a large-for-gestational age (LGA) infant than those whose weight gain falls within standard guidelines, according to a recent study in Obstetrics & Gynecology.
Researchers from the Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention analyzed linked birth certificates and maternal hospital discharge data on live, singleton deliveries in Florida from 2004 to 2008. Multivariable logistic regression was used to assess the independent contributions of the mother’s prepregnancy body mass index (BMI), gestational weight gain, and gestational diabetes mellitus (GDM) status on the risk of a LGA infant by race and ethnicity, while controlling for maternal age, nativity, and parity.
Prevalence of LGA infants was 5.7% in normal-weight women with adequate gestational weight gain and no GDM. Prevalence among women with BMI ≥25 was 12.6% and 13.5% among women who had excess gestational weight gain. Among women with GDM, the prevalence of LGA infants was 17.3%. Across all race or ethnic groups, GDM contributed the least to LGA (2.0% to 8.0%) whereas excessive weight gain contributed the most (33.3% to 37.7%). The authors estimated that Asian and Pacific Islanders and non-Hispanic black women might have 46.8% and 61.0% fewer LGA births, respectively, if they had none of the three exposures.
Concluding that excessive maternal weight gain is the greatest risk factor for LGA infants, the investigators urged ob/gyns to provide pregnant patients with guidelines for gestational weight gain and counsel those whose weight during pregnancy is too high.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Fasting glucose at GDM diagnosis may predict postpartum glucose abnormalities
February 6th 2025A recent study suggests that elevated fasting glucose levels at the time of gestational diabetes diagnosis could be an early indicator of postpartum glucose intolerance, emphasizing the need for close monitoring after delivery.
Read More
Ulipristal plus misoprostol shows promise for medication abortion
February 5th 2025A recent study found that ulipristal acetate followed by misoprostol is a safe, effective, and acceptable option for medication abortion, offering a potential alternative in areas with limited access to mifepristone.
Read More
Identification and management of patients at increased risk for breast cancer
February 5th 2025With breast cancer being the most diagnosed invasive cancer in the United States, OB-GYN practitioners play a crucial role in identifying high-risk patients and guiding them through screening, prevention, and risk-reduction strategies.
Read More